LadRx (NASDAQ:CYTR) Research Coverage Started at StockNews.com
LadRx (NASDAQ:CYTR) Research Coverage Started at StockNews.com
LadRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. Stock analysts at StockNews.com assumed coverage on shares of LadRx (NASDAQ:CYTR – Get Rating) in a research note issued on Sunday. The firm set a "hold" rating on the stock.
股票分析師在股票新聞承擔的股份覆蓋 LaDrX (納斯達克:賽爾特 — 獲得評分) 在星期日發布的一份研究報告中。該公司對股票設定了「持有」評級。
LadRx Price Performance
價格表現
LadRx has a 1 year low of $0.05 and a 1 year high of $0.86. The stock has a fifty day moving average of $0.09.
LADRX 擁有 1 年低點 0.05 美元和 1 年的最高點為 0.86 美元。該股票的五十天移動平均線為 0.09 美元。
About LadRx
關於我們
(Get Rating)
(取得評分)
LadRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor.
LADRX Corp. 是一家生物製藥研發公司，致力於新型抗癌候選藥物的發現、研究和臨床開發。它專注於開發 Linker 活性藥物釋放（LADR）技術平台，該平台是一種發現引擎，可幫助創建一系列抗癌分子，避免無法接受的全身毒性，同時將高效藥物直接輸送到腫瘤中。
Featured Stories
特色故事
- Get a free copy of the StockNews.com research report on LadRx (CYTR)
- MarketBeat Week in Review – 2/27 – 3/3
- The 3 Most Upgraded Stocks Are Reversing
- How to Find Blue Chip Dividend Stocks
- Zscaler, Inc Plummets, Is It Time To Buy The Dip?
- What is a Good Dividend Yield? How to Decide
- 獲取有關 LADRX 研究報告的免費副本
- 市場節拍週的回顧 — 2/27 — 3/3
- 3 個最升級的股票正在倒轉
- 如何查找藍籌股息股票
- 茲斯卡爾公司暴跌，是時候購買蘸料了嗎？
- 什麼是良好的股息收益率？如何決定
Receive News & Ratings for LadRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LadRx and related companies with MarketBeat.com's FREE daily email newsletter.
接收有關 LaDrX 每日的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收對 LADRX 及相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。
